Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
BMJ Global Health
|
May 24, 2025
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial
Kate Shearer, Bareng A S Nonyane, Christiaan Mulder, et al.
Annals of Internal Medicine
|
August 23, 2021
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial
Gavin Churchyard, Vicky Cárdenas, Violet Chihota, et al.
Plos One
|
May 10, 2016
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis
Marcus B Conde, Fernanda C Q Mello, Rafael Silva Duarte, et al.
Antimicrobial Agents and Chemotherapy
|
May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
Nicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, et al.
Emerging Infectious Diseases
|
March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 18, 2003
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
Henry M Blumberg, William J Burman, Richard E Chaisson, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
Emerging Infectious Diseases
|
January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020
Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
BMJ Global Health
|
May 24, 2025
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial
Kate Shearer, Bareng A S Nonyane, Christiaan Mulder, et al.
Annals of Internal Medicine
|
August 23, 2021
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial
Gavin Churchyard, Vicky Cárdenas, Violet Chihota, et al.
Plos One
|
May 10, 2016
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis
Marcus B Conde, Fernanda C Q Mello, Rafael Silva Duarte, et al.
Antimicrobial Agents and Chemotherapy
|
May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
Nicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, et al.
Emerging Infectious Diseases
|
March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 18, 2003
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
Henry M Blumberg, William J Burman, Richard E Chaisson, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
Emerging Infectious Diseases
|
January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020
Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.
Page
of 25